If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA’s drug shortage list.
If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA’s drug shortage list.
